Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 5.5T | 5.3T | 5.0T | 4.5T |
Cost of revenue | 3.8T | 3.7T | 3.6T | 3.2T |
Gross profit | 1.7T | 1.5T | 1.4T | 1.3T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3T | 1.2T | 1.1T | 1.0T |
Other operating expenses | -15.4B | -19.9B | -3.4B | -1.2B |
Operating income | 391.9B | 328.5B | 262.4B | 252.1B |
Non operating interest income | ||||
Income | 20.8B | 21.2B | 12.3B | 11.9B |
Expense | 14.4B | 11.7B | 4.3B | 2.7B |
Other income expense | — | — | — | — |
Pretax income | 437.3B | 365.9B | 292.2B | 279.7B |
Tax provision | 90.3B | 68.9B | 67.2B | 61.8B |
Net income | 346.9B | 296.9B | 224.9B | 217.9B |
Basic EPS | — | 271.5 | 202.6 | 190.8 |
Diluted EPS | — | 271.5 | 202.6 | 190.8 |
Basic average shares | — | 1.0B | 1.1B | 164.9B |
Diluted average shares | — | 1.0B | 1.1B | 164.9B |
EBITDA | 673.1B | 578.4B | 510.3B | 489.2B |
Net income from continuing op. | 346.9B | 296.9B | 224.9B | 217.9B |
Minority interests | -22.8B | -12.0B | -11.0B | -14.4B |
Preferred stock dividends | 0 | 0 | 0 | 0 |